デジタル治療薬市場規模・シェア・動向分析レポート:アプリケーション別(糖尿病、肥満、CVD)、エンドユーザー別(患者、プロバイダー、支払者、雇用者)、地域別、セグメント予測、2022年~2030年Digital Therapeutics Market Size, Share & Trends Analysis Report By Application (Diabetes, Obesity, CVD), By End User (Patients, Providers, Payers, Employers), By Region, And Segment Forecasts, 2022 - 2030 デジタルセラピューティック市場の成長と動向 Grand View Research, Inc.の最新レポートによると、デジタル治療薬の世界市場規模は、2030年までに325億米ドルに達する見込みです。この市場は、2022年から2030... もっと見る
※当ページの内容はウェブ更新時の情報です。
サマリーデジタルセラピューティック市場の成長と動向Grand View Research, Inc.の最新レポートによると、デジタル治療薬の世界市場規模は、2030年までに325億米ドルに達する見込みです。この市場は、2022年から2030年にかけて、26.1%の有利なCAGRで成長すると予想されています。市場成長の主な要因としては、COVID-19のパンデミックによる需要の高まり、様々な支援的な規制イニシアチブと償還の初期兆候、先進国および発展途上国におけるスマートフォンの普及率の上昇、慢性疾患の有病率の上昇などが挙げられます。さらに、医療機関や患者にとってデジタルヘルス技術は費用対効果が高く、統合医療システムや患者中心のケアに対する需要が高まっていることも、市場の成長を後押しすると考えられます。 COVID-19パンデミックは、デジタル治療ソリューションの導入を促進しました。Teladoc社の報告によると、遠隔医療の利用はパンデミック前の約38倍に増加しています。これらのソリューションの導入は、FDAなどの主要規制機関による支援策によっても支えられました。例えば、米国のFDAは2020年4月に、精神科患者に対するデジタルヘルス治療機器の利用を拡大するためのガイドラインを発表しました。Kepios社の調査によると、世界のインターネットユーザー数は年率7.6%で増加しており、毎日平均90万人のユーザーが新たに加わっていることになります。先進国や一部の発展途上国では、スマートフォンやインターネットの普及率が高い一方で、アフリカや南アジアなどの地域では、経済が発展していないために遅れています。 アフリカのスマートフォン市場は、ユーザー数が少ないながらも、手頃な価格の携帯電話が登場したことで、今後の成長が期待されています。これらの携帯電話は、1台あたりの価格が100米ドル以下で、人気を集めています。医療費の増加に伴い、費用対効果の高いヘルスケアへのニーズが高まっています。慢性疾患の発生率の上昇により、医療費が増加しています。このことは、発展途上国や先進国の経済成長に影響を与えています。より安価で代替的な医療提供手段を促進するために、追加コストを回避するためのデジタルヘルス技術が奨励されています。mHealthアプリケーションの使いやすさとその安定した性能は、個人やコミュニティの健康状態の改善に役立ち、市場の成長にプラスの影響を与えると予想されます。 デジタルセラピューティクス市場レポートのハイライト - 2021年には、糖尿病の有病率の高さから、糖尿病アプリケーションセグメントが市場を支配しました - 患者によるデジタル治療ソリューションの導入が進んでいることから、2021年には患者向けエンドユーザーセグメントが最大の収益シェアを占めました - 2021年には、デジタルヘルス製品の使用が増加し、追跡・診断機能の向上による生活の質の向上に焦点を当てた有利な償還シナリオにより、北米が地域別市場の中心となりました。 - アジア太平洋地域は、パーソナル・ケア・デバイスと関連サービスの需要が高まっていることから、予測期間中に最も速いCAGRを記録すると予想されています。 目次Table of ContentsChapter 1 Research Methodology & Scope 1.1 Market Segmentation & Scope 1.1.1 Estimates And Forecast Timeline 1.2 Research Methodology 1.3 Information Procurement 1.3.1 Purchased database 1.3.2 GVR’s Internal Database 1.3.3 Secondary sources 1.3.4 Primary Research: 1.3.5 Details of Primary Research 1.4 Information Or Data Analysis 1.4.1 Data Analysis Models 1.5 Market Formulation & Validation 1.6 Model Details 1.6.1 Commodity Flow Analysis (Model 1) 1.6.2 Demand Sizing: Disease Prevalence Based Model 1.6.3 Region Based Segment Share Calculation 1.7 List Of Secondary Sources 1.8 List Of Primary Sources 1.9 Report Objectives Chapter 2 Executive Summary 2.1 Market Outlook 2.1.1 Digital Therapeutics Market Outlook, 2017 - 2030 (USD Million) 2.2 Digital Therapeutics Market Summary, 2021 Chapter 3 Digital Therapeutics Market Variables, Trends & Scope 3.1 Market Lineage Outlook 3.1.1 Parent Market Analysis 3.1.2 Ancillary Market Analysis 3.2 Penetration & Growth Prospect Mapping 3.3 Digital Therapeutics Market Dynamics 3.3.1 Market driver analysis 3.3.1.1 COVID-19 pandemic 3.3.1.2 Supportive regulatory initiatives & early signs of reimbursement 3.3.1.3 Increasing prevalence of chronic diseases 3.3.1.4 increasing smartphone penetration in developed and developing countries 3.3.1.5 cost-effectiveness of digital health technology for providers and patients 3.3.1.6 increasing demand for integrated healthcare systems and patient-centric care 3.3.2 Market restraint analysis 3.3.2.1 low smartphone penetration in underdeveloped countries 3.3.2.2 COncerns over data protection 3.4 Digital Therapeutics Market Analysis Tools: Porter’s Five Forces Analysis 3.4.1 Supplier Power: Low 3.4.2 Buyer Power: high 3.4.3 Threat Of Substitutes: Low 3.4.4 Threat Of New Entrants: High 3.4.5 Competitive Rivalry: High 3.5 Pestel Analysis 3.5.1 Political & Legal Landscape 3.5.2 Economic Landscape 3.5.3 Social & Technological Landscape 3.6 Opportunity Analysis Chapter 4 Digital Therapeutics Market: Competitive Analysis 4.1 Market Participation Categorization 4.1.1 Market Leaders & Innovators 4.1.1.1 company market position analysis 4.2 Major Deals & Strategic Alliances Analysis 4.2.1 List Of Private Companies Chapter 5 Digital Therapeutics Market: Covid-19 Impact 5.1 Disease Prevalence Analysis 5.2 Current And Future Impact Analysis 5.2.1 Current Impact Analysis 5.2.2 Future Impact Analysis 5.3 Impact On Market Players Chapter 6 Digital Therapeutics Market: Application Estimates & Trend Analysis 6.1 Application Market Share Analysis, 2021 & 2030 6.2 Application Dashboard 6.3 Diabetes 6.3.1 diabetes market estimates and forecasts, 2017 - 2030 (USD Million) 6.4 OBESITY 6.4.1 obesity market estimates and forecasts, 2017 - 2030 (USD Million) 6.5 CVD 6.5.1 CVD market estimates and forecasts, 2017 - 2030 (USD Million) 6.6 Respiratory Diseases 6.6.1 Respiratory diseases market estimates and forecasts, 2017 - 2030 (USD Million) 6.7 Smoking Cessation 6.7.1 Smoking cessation market estimates and forecasts, 2017 - 2030 (USD Million) 6.8 CNS DISEASES 6.8.1 CNS Diseases market estimates and forecasts, 2017 - 2030 (USD Million) 6.9 OTHERS 6.9.1 Others market estimates and forecasts, 2017 - 2030 (USD Million) Chapter 7 Digital Therapeutics Market: End-Use Estimates & Trend Analysis 7.1 End-Use Market Share Analysis, 2021 & 2030 7.2 End-Use Dashboard 7.3 Patients 7.3.1 Patients Market Estimates And Forecasts, 2017 - 2030 (USD Million) 7.4 Providers 7.4.1 Providers market estimates and forecasts, 2017 - 2030 (USD Million) 7.5 Payers 7.5.1 payers market estimates and forecasts, 2017 - 2030 (USD Million) 7.6 Employers 7.6.1 employers market estimates and forecasts, 2017 - 2030 (USD Million) 7.7 Other End Users 7.7.1 Other End Users market estimates and forecasts, 2017 - 2030 (USD Million) Chapter 8 Digital Therapeutics Market: Regional Estimates & Trend Analysis, by Application, End-Use 8.1 Regional Market Snapshot 8.2 North America 8.2.1 North America Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million) 8.2.2 U.S. 8.2.2.1 U.S. Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million) 8.2.3 Canada 8.2.3.1 Canada Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million) 8.3 Europe 8.3.1 Europe Digital Therapeutics Market estimates and forecasts, 2017 - 2030 (USD Million) 8.3.2 U.K. 8.3.2.1 U.K. Digital Therapeutics market estimates and forecasts, 2017 - 2030(USD Million) 8.3.3 Germany 8.3.3.1 Germany Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million) 8.3.4 France 8.3.4.1 France Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million) 8.3.5 Italy 8.3.5.1 Italy Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million) 8.3.6 Spain 8.3.6.1 Spain Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million) 8.4 Asia Pacific 8.4.1 Asia Pacific Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million) 8.4.2 Japan 8.4.2.1 Japan Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million) 8.4.3 China 8.4.3.1 China Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million) 8.4.4 India 8.4.4.1 India Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million) 8.5 Latin America 8.5.1 Latin America Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million) 8.5.2 Mexico 8.5.2.1 Mexico Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million) 8.5.3 Brazil 8.5.3.1 Brazil Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million) 8.5.4 Argentina 8.5.4.1 Argentina Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million) 8.6 Middle East And Africa (MEA) 8.6.1 Middle East and Africa Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million) 8.6.2 South Africa 8.6.2.1 South Africa Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million) 8.6.3 Saudi Arabia 8.6.3.1 Saudi Arabia Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million) Chapter 9 Company Profiles 9.1 OMADA HEALTH, INC. 9.1.1 Company overview 9.1.2 Financial performance 9.1.3 Product benchmarking 9.1.4 Strategic initiatives 9.2 WELLDOC, INC. 9.2.1 Company Overview 9.2.2 Financial Performance 9.2.3 Product Benchmarking 9.2.4 Strategic Initiatives 9.3 2Morrow, Inc 9.3.1 Company Overview 9.3.2 Financial Performance 9.3.3 Product Benchmarking 9.3.4 STRATEGIC INITIATIVES 9.4 LIVONGO HEALTH, INC. (TELADOC HEALTH, INC.) 9.4.1 Company Overview 9.4.2 Financial Performance 9.4.3 Product Benchmarking 9.4.4 Strategic Initiatives 9.5 PROPELLER HEALTH 9.5.1 Company Overview 9.5.2 Financial PERFORMANCE 9.5.3 Product Benchmarking 9.5.4 Strategic Initiatives 9.6 Fitbit, Inc. 9.6.1 Company Overview 9.6.2 Financial Performance 9.6.3 Product Benchmarking 9.6.4 STRATEGIC INITIATIVES 9.7 CANARY HEALTH 9.7.1 Company Overview 9.7.2 Financial Performance 9.7.3 Product Benchmarking 9.7.4 Strategic Initiatives 9.8 MANGO HEALTH 9.8.1 Company Overview 9.8.2 Financial Performance 9.8.3 Product Benchmarking 9.8.4 STRATEGIC INITIATIVES 9.9 NOOM, INC. 9.9.1 Company Overview 9.9.2 Financial Performance 9.9.3 Product Benchmarking 9.9.4 STRATEGIC INITIATIVES 9.10 PEAR THERAPEUTICS 9.10.1 Company Overview 9.10.2 Financial Performance 9.10.3 Product Benchmarking 9.10.4 STRATEGIC INITIATIVES
SummaryDigital Therapeutics Market Growth & Trends Table of ContentsTable of ContentsChapter 1 Research Methodology & Scope 1.1 Market Segmentation & Scope 1.1.1 Estimates And Forecast Timeline 1.2 Research Methodology 1.3 Information Procurement 1.3.1 Purchased database 1.3.2 GVR’s Internal Database 1.3.3 Secondary sources 1.3.4 Primary Research: 1.3.5 Details of Primary Research 1.4 Information Or Data Analysis 1.4.1 Data Analysis Models 1.5 Market Formulation & Validation 1.6 Model Details 1.6.1 Commodity Flow Analysis (Model 1) 1.6.2 Demand Sizing: Disease Prevalence Based Model 1.6.3 Region Based Segment Share Calculation 1.7 List Of Secondary Sources 1.8 List Of Primary Sources 1.9 Report Objectives Chapter 2 Executive Summary 2.1 Market Outlook 2.1.1 Digital Therapeutics Market Outlook, 2017 - 2030 (USD Million) 2.2 Digital Therapeutics Market Summary, 2021 Chapter 3 Digital Therapeutics Market Variables, Trends & Scope 3.1 Market Lineage Outlook 3.1.1 Parent Market Analysis 3.1.2 Ancillary Market Analysis 3.2 Penetration & Growth Prospect Mapping 3.3 Digital Therapeutics Market Dynamics 3.3.1 Market driver analysis 3.3.1.1 COVID-19 pandemic 3.3.1.2 Supportive regulatory initiatives & early signs of reimbursement 3.3.1.3 Increasing prevalence of chronic diseases 3.3.1.4 increasing smartphone penetration in developed and developing countries 3.3.1.5 cost-effectiveness of digital health technology for providers and patients 3.3.1.6 increasing demand for integrated healthcare systems and patient-centric care 3.3.2 Market restraint analysis 3.3.2.1 low smartphone penetration in underdeveloped countries 3.3.2.2 COncerns over data protection 3.4 Digital Therapeutics Market Analysis Tools: Porter’s Five Forces Analysis 3.4.1 Supplier Power: Low 3.4.2 Buyer Power: high 3.4.3 Threat Of Substitutes: Low 3.4.4 Threat Of New Entrants: High 3.4.5 Competitive Rivalry: High 3.5 Pestel Analysis 3.5.1 Political & Legal Landscape 3.5.2 Economic Landscape 3.5.3 Social & Technological Landscape 3.6 Opportunity Analysis Chapter 4 Digital Therapeutics Market: Competitive Analysis 4.1 Market Participation Categorization 4.1.1 Market Leaders & Innovators 4.1.1.1 company market position analysis 4.2 Major Deals & Strategic Alliances Analysis 4.2.1 List Of Private Companies Chapter 5 Digital Therapeutics Market: Covid-19 Impact 5.1 Disease Prevalence Analysis 5.2 Current And Future Impact Analysis 5.2.1 Current Impact Analysis 5.2.2 Future Impact Analysis 5.3 Impact On Market Players Chapter 6 Digital Therapeutics Market: Application Estimates & Trend Analysis 6.1 Application Market Share Analysis, 2021 & 2030 6.2 Application Dashboard 6.3 Diabetes 6.3.1 diabetes market estimates and forecasts, 2017 - 2030 (USD Million) 6.4 OBESITY 6.4.1 obesity market estimates and forecasts, 2017 - 2030 (USD Million) 6.5 CVD 6.5.1 CVD market estimates and forecasts, 2017 - 2030 (USD Million) 6.6 Respiratory Diseases 6.6.1 Respiratory diseases market estimates and forecasts, 2017 - 2030 (USD Million) 6.7 Smoking Cessation 6.7.1 Smoking cessation market estimates and forecasts, 2017 - 2030 (USD Million) 6.8 CNS DISEASES 6.8.1 CNS Diseases market estimates and forecasts, 2017 - 2030 (USD Million) 6.9 OTHERS 6.9.1 Others market estimates and forecasts, 2017 - 2030 (USD Million) Chapter 7 Digital Therapeutics Market: End-Use Estimates & Trend Analysis 7.1 End-Use Market Share Analysis, 2021 & 2030 7.2 End-Use Dashboard 7.3 Patients 7.3.1 Patients Market Estimates And Forecasts, 2017 - 2030 (USD Million) 7.4 Providers 7.4.1 Providers market estimates and forecasts, 2017 - 2030 (USD Million) 7.5 Payers 7.5.1 payers market estimates and forecasts, 2017 - 2030 (USD Million) 7.6 Employers 7.6.1 employers market estimates and forecasts, 2017 - 2030 (USD Million) 7.7 Other End Users 7.7.1 Other End Users market estimates and forecasts, 2017 - 2030 (USD Million) Chapter 8 Digital Therapeutics Market: Regional Estimates & Trend Analysis, by Application, End-Use 8.1 Regional Market Snapshot 8.2 North America 8.2.1 North America Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million) 8.2.2 U.S. 8.2.2.1 U.S. Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million) 8.2.3 Canada 8.2.3.1 Canada Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million) 8.3 Europe 8.3.1 Europe Digital Therapeutics Market estimates and forecasts, 2017 - 2030 (USD Million) 8.3.2 U.K. 8.3.2.1 U.K. Digital Therapeutics market estimates and forecasts, 2017 - 2030(USD Million) 8.3.3 Germany 8.3.3.1 Germany Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million) 8.3.4 France 8.3.4.1 France Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million) 8.3.5 Italy 8.3.5.1 Italy Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million) 8.3.6 Spain 8.3.6.1 Spain Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million) 8.4 Asia Pacific 8.4.1 Asia Pacific Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million) 8.4.2 Japan 8.4.2.1 Japan Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million) 8.4.3 China 8.4.3.1 China Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million) 8.4.4 India 8.4.4.1 India Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million) 8.5 Latin America 8.5.1 Latin America Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million) 8.5.2 Mexico 8.5.2.1 Mexico Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million) 8.5.3 Brazil 8.5.3.1 Brazil Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million) 8.5.4 Argentina 8.5.4.1 Argentina Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million) 8.6 Middle East And Africa (MEA) 8.6.1 Middle East and Africa Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million) 8.6.2 South Africa 8.6.2.1 South Africa Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million) 8.6.3 Saudi Arabia 8.6.3.1 Saudi Arabia Digital Therapeutics market estimates and forecasts, 2017 - 2030 (USD Million) Chapter 9 Company Profiles 9.1 OMADA HEALTH, INC. 9.1.1 Company overview 9.1.2 Financial performance 9.1.3 Product benchmarking 9.1.4 Strategic initiatives 9.2 WELLDOC, INC. 9.2.1 Company Overview 9.2.2 Financial Performance 9.2.3 Product Benchmarking 9.2.4 Strategic Initiatives 9.3 2Morrow, Inc 9.3.1 Company Overview 9.3.2 Financial Performance 9.3.3 Product Benchmarking 9.3.4 STRATEGIC INITIATIVES 9.4 LIVONGO HEALTH, INC. (TELADOC HEALTH, INC.) 9.4.1 Company Overview 9.4.2 Financial Performance 9.4.3 Product Benchmarking 9.4.4 Strategic Initiatives 9.5 PROPELLER HEALTH 9.5.1 Company Overview 9.5.2 Financial PERFORMANCE 9.5.3 Product Benchmarking 9.5.4 Strategic Initiatives 9.6 Fitbit, Inc. 9.6.1 Company Overview 9.6.2 Financial Performance 9.6.3 Product Benchmarking 9.6.4 STRATEGIC INITIATIVES 9.7 CANARY HEALTH 9.7.1 Company Overview 9.7.2 Financial Performance 9.7.3 Product Benchmarking 9.7.4 Strategic Initiatives 9.8 MANGO HEALTH 9.8.1 Company Overview 9.8.2 Financial Performance 9.8.3 Product Benchmarking 9.8.4 STRATEGIC INITIATIVES 9.9 NOOM, INC. 9.9.1 Company Overview 9.9.2 Financial Performance 9.9.3 Product Benchmarking 9.9.4 STRATEGIC INITIATIVES 9.10 PEAR THERAPEUTICS 9.10.1 Company Overview 9.10.2 Financial Performance 9.10.3 Product Benchmarking 9.10.4 STRATEGIC INITIATIVES
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療/ヘルスケア)の最新刊レポート
Grand View Research 社の最新刊レポート
本レポートと同じKEY WORD(diabetes)の最新刊レポート
よくあるご質問Grand View Research社はどのような調査会社ですか?グランドビューリサーチ(Grand View Research)は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/12 10:26 154.83 円 165.45 円 201.96 円 |